๐Ÿ“–
Hormonal contraceptives and cancer risk in women with a BRCA1 or BRCA2 pathogenic variant.
Nahshon C, Fahoum L, Hadar D, Cohen H, Michaelson-Cohen R, Regev S, Schmidt M, Assaf W, Narod SA, Segev Y

Hormonal contraceptives and cancer risk in women with a BRCA1 or BRCA2 pathogenic variant.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Breast Cancer.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Hormonal contraceptives and cancer risk in women with a BRCA1 or BRCA2 pathogenic variant.
Author / Organization Nahshon C, Fahoum L, Hadar D, Cohen H, Michaelson-Cohen R, Regev S, Schmidt M, Assaf W, Narod SA, Segev Y
Subject & Discipline Breast Cancer
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-6266
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »